Cell-Based Analysis: Company Announcements

Reichert Analytical Instruments licensed the University of Buffalo’s technology for the creation of a cell volume cytometer for research and diagnostic applications.

Amaxa AG is one of eight companies involved in the EU’s MODEST-EU project to develop devices for ultra high-throughput delivery and screening of primary cells.

Accuri Cytometers named George Dunbar, president and CEO of Aastrom Biosciences, and Dan Calvo, president and CEO of Assay Designs, to its Board.

CompuCyte and Cold Spring Harbor Laboratory established the Regional Quantitative Image Cytometry Center of Excellence.

In July, Cellumen raised $8.7 million in Series B financing, led by Safeguard Scientifics.

Cyntellect completed $15.1 million Series D private financing in July, which was led by Third Security.

In August, the Immune Tolerance Network (ITN) Flow Cytometry Core Laboratory opened at Beckman Coulter’s Miami, Florida, location. Beckman Coulter will participate in the planning of ITN’s clinical trials related to allergy, asthma and autoimmune diseases, and transplantation.

IonGate Biosciences GmbH and LIVC Technologies GmbH signed a development and marketing agreement.

< | >